Optimization of the diagnosis of cardiovascular adverse events in patients with non-Hodgkin lymphomas
Aim. To identify the optimal combination of cardiovascular toxicity (CVT) markers for subsequent optimization of the diagnosis of cardiovascular adverse events in patients with non-Hodgkin lymphomas.Material and methods. This prospective study was conducted to monitor cardiovascular adverse events i...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
«SILICEA-POLIGRAF» LLC
2026-04-01
|
| Col·lecció: | Кардиоваскулярная терапия и профилактика |
| Matèries: | |
| Accés en línia: | https://cardiovascular.elpub.ru/jour/article/view/4514 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|